SYNERGISTIC EFFECT OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE (4-HC) AND CISPLATIN (CP) FOR EXVIVO BONE-MARROW PURGING

被引：0
作者：
PETERS, RH [1 ]
STUART, RK [1 ]
机构：
[1] MED UNIV S CAROLINA,CHARLESTON,SC 29425
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1987年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：415 / 415
页数：1
相关论文
共 50 条
  • [31] Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging produces durable remissions in patients with follicular lymphoma.
    Flinn, IW
    Jones, RJ
    Garrett, E
    Miller, CB
    Gore, SD
    Smith, G
    Ambinder, RF
    BLOOD, 2003, 102 (11) : 735A - 735A
  • [32] Human A1, a Bcl-2 related gene, protects against 4-hydroperoxycyclophosphamide (4-HC) toxicity.
    Moreb, J
    Schweder, A
    BLOOD, 1997, 90 (10) : 3484 - 3484
  • [33] AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE-LEUKEMIA - A PILOT-STUDY UTILIZING INVITRO INCUBATION OF AUTOLOGOUS MARROW WITH 4-HYDROPEROXYCYCLOPHOSPHAMIDE (4HC) PRIOR TO CRYOPRESERVATION
    KAIZER, H
    STUART, RK
    COLVIN, M
    KORBLING, M
    WHARAM, MD
    SANTOS, GW
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 483 - 483
  • [34] THE EFFECT OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) ON THE PROLIFERATION OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE (4-HC) RESISTANT PROGENITORS IN LIQUID CULTURE
    SAFAH, H
    ZUCALI, J
    MOREB, J
    BLOOD, 1993, 82 (10) : A653 - A653
  • [35] FUNCTIONAL SEPARATION OF HUMAN SUPPRESSOR AND CYTO-TOXIC T-SUBSETS DEFINED INVITRO BY 4-HYDROPEROXYCYCLOPHOSPHAMIDE (4-HC)
    SMITH, J
    COWENS, W
    NUSSBAUMBLUMENSON, A
    SHEEDY, D
    MIHICH, E
    OZER, H
    FEDERATION PROCEEDINGS, 1982, 41 (03) : 797 - 797
  • [36] REACTIVATION OF POLYCLONAL HEMATOPOIESIS IN CHRONIC MYELOGENOUS LEUKEMIA AFTER INVITRO BONE-MARROW TREATMENT WITH 4-HYDROPEROXYCYCLOPHOSPHAMIDE
    DEGLIANTONI, G
    MEDICINA-RIVISTA DELLA ENCICLOPEDIA MEDICA ITALIANA, 1984, 4 (01): : 66 - 68
  • [37] SUBSEQUENT EXPOSURE TO METHYLPREDNISOLONE (MP) ENHANCES CYTOTOXICITY OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE (4-HC) FOR K562 BUT NOT FOR HUMAN CFU-GM
    ZUHLSDORF, M
    ROWLEY, SD
    HILTON, J
    BRAINE, HG
    COLVIN, OM
    SANTOS, GW
    BLUT, 1987, 55 (04): : 385 - 385
  • [38] STUDY OF INVITRO SENSITIVITY OF HUMAN-LEUKEMIC CELLS AND NORMAL HEMATOPOIETIC PROGENITORS TO 4-HYDROPEROXYCYCLOPHOSPHAMIDE (4 HC) - THE INTEREST FOR THE PREPARATION OF ANTILEUKEMIC AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    GORIN, NC
    DOUAY, L
    NAJMAN, A
    BAILLOU, C
    DUHAMEL, G
    EXPERIMENTAL HEMATOLOGY, 1982, 10 : 13 - 13
  • [39] Autologous bone marrow transplantation (ABMT) using 4-hydroperoxycyclophosphamide (4HC) purging for acute myeloid leukemia (AML) beyond first remission: A ten-year experience.
    Smith, BD
    Jones, RJ
    Piantadosi, S
    Lee, SM
    Vala, MS
    Gore, SD
    Noga, SJ
    Miller, CB
    BLOOD, 1998, 92 (10) : 323A - 323A
  • [40] AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HIGH-RISK REMISSION T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA USING IMMUNOTOXINS PLUS 4-HYDROPEROXYCYCLOPHOSPHAMIDE FOR MARROW PURGING
    UCKUN, FM
    KERSEY, JH
    VALLERA, DA
    LEDBETTER, JA
    WEISDORF, D
    MYERS, DE
    HAAKE, R
    RAMSAY, NKC
    BLOOD, 1990, 76 (09) : 1723 - 1733
12345